ACM Research, Inc. develops, manufactures and sells wafer and panel processing equipment for semiconductor manufacturing and advanced packaging applications. Company news commonly covers financial results, shipment trends, customer orders, and product introductions across cleaning, electroplating, stress-free polishing, vertical furnace, track, PECVD, and wafer- and panel-level packaging tools.
Recurring updates also include ACM’s ACM Planetary Family product organization, advanced packaging platforms, global customer activity, production-capacity initiatives, and disclosures involving ACM Research (Shanghai), Inc., the company’s principal operating subsidiary listed on the Shanghai Stock Exchange STAR Market.
Alvotech (NASDAQ: ALVO), Kashiv Biosciences, and Advanz Pharma announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted a marketing application for AVT23, a proposed biosimilar to Xolair® (omalizumab). The biosimilar targets treatments for severe persistent allergic asthma and chronic rhinosinusitis with nasal polyps.
Xolair recorded global sales of $4.4 billion in 2024. The development builds on previous partnerships, including a February 2023 commercialization agreement between Alvotech and Advanz Pharma for AVT23, which was expanded in May 2023 to include five additional biosimilar candidates. Additionally, Alvotech and Kashiv established a licensing agreement for AVT23 in October 2023.
ACM Research has released preliminary unaudited financial results for Q1 2025, projecting revenue between $165-170 million, representing 8.4-11.7% year-over-year growth. The semiconductor equipment supplier reported:
- Expected Q1 2025 total shipments of $154-157 million, showing a 36-37% year-over-year decrease due to Q4 2024 customer pull-ins
- Combined Q4 2024 and Q1 2025 shipments expected to grow 8-9% versus prior year periods
- Reaffirmed full-year 2025 revenue outlook of $850-950 million, targeting 9-21% annual growth
ACM Shanghai, the company's main operating subsidiary (81.1% owned), will report separate results in RMB under Chinese accounting standards. The parent company will discuss complete Q1 2025 results during its May 8 earnings call.
ACM Research (NASDAQ: ACMR) has announced its upcoming financial results schedule for Q1 2025. The company will release its preliminary revenue range on April 29, 2025, before U.S. market open, aligning with the reporting requirements of ACM Research (Shanghai) to the Shanghai Stock Exchange.
The complete Q1 2025 financial results will be disclosed on May 8, 2025, before U.S. market open, followed by a conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. China Time). Participants can join via telephone through pre-registration or access the webcast through the company's investor relations website.
ACM Research (NASDAQ: ACMR) has won the 2025 3D InCites Award in the Technology Enablement category for its Ultra ECP ap-p tool, a groundbreaking solution for fan-out panel-level packaging (FOPLP). The system is the first commercially-available high-volume copper deposition system for the large panel market.
The tool supports panel sizes of 515 mm x 510 mm and 600 mm x 600 mm, utilizing a horizontal plating approach for superior uniformity and precision. It can be used for various plating processes including pillar, bump and redistribution layer. The award recognizes ACM's contribution to solving critical challenges in heterogeneous integration.
ACM's FOPLP portfolio includes:
- Ultra ECP ap-p for copper deposition
- Ultra C vac-p for flux cleaning
- Ultra C bev-p for bevel etching and cleaning
ACM Research (NASDAQ: ACMR) has appointed Charlie Pappis to its Board of Directors, effective March 15, 2025. This addition expands the board to five members, supporting ACM's long-term growth strategy. Pappis brings over 40 years of semiconductor industry leadership experience, currently serving as President of Pappis Consulting.
A semiconductor industry veteran, Pappis previously held executive leadership roles during a 30+ year tenure at a major U.S.-based semiconductor equipment company. He holds a BS in Materials Science from Worcester Polytechnic Institute and an Executive MBA from Stanford University.
The appointment aligns with ACM's mission to become a key supplier of capital equipment to major global semiconductor companies, with particular focus on increasing investments and business expansion in the U.S. market beyond mainland China.
ACM Research (NASDAQ: ACMR), a provider of wafer processing solutions for semiconductor and advanced packaging applications, has announced its participation in the 37th Annual ROTH Conference in Dana Point, California.
The event is scheduled for March 17, 2025, where the company's management team will be available to engage with institutional investors through one-on-one and small group meetings. Interested institutional investors can arrange meetings through ROTH sales representatives.
ACM Research (NASDAQ: ACMR) announced the qualification of its Single-Wafer High-Temperature Sulfuric Peroxide Mixture (SPM) tool by a major logic device manufacturer in China. The company has delivered SPM tools to thirteen customers, featuring a proprietary nozzle design that prevents acid mist splatter and improves system performance.
The tool supports wet etching and wafer cleaning for both front- and back-end processes at 28-nanometer and below technology nodes. It operates at various temperature ranges, from 90°C for sulfuric acid cleaning to 190°C for metal lift-off processes. Key features include a multi-level heating method maintaining temperatures above 230℃ and superior particle control with fewer than 10 particles at 26nm.
The system includes an inline chemical mixing system and can be integrated with ACM's SAPS and TEBO megasonic technologies for enhanced organic contaminant removal.
ACM Research (NASDAQ: ACMR) reported strong financial results for Q4 and FY 2024. Revenue reached $782.1 million for the full year, up 40.2%, with Q4 revenue of $223.5 million, up 31.2% year-over-year. The company achieved a gross margin of 50.1% and operating income of $151.0 million, up 57.6%.
Total shipments in 2024 increased by 63.1% to $973 million. The company achieved process qualification of its Thermal and Plasma-Enhanced ALD furnace tools at two semiconductor customers in mainland China and commenced operations at its Lingang production facility.
For fiscal year 2025, ACM maintains its revenue guidance of $850-950 million and has updated its long-term gross margin target range to 42-48%. Despite being added to the U.S. Entity List, management believes the impact on ACM Research (Shanghai)'s production capabilities will be manageable.